Brief: HLS Therapeutics Announces Q3 Fiscal 2021 Financial Results
04/11/2021 12:53
Nov 4 (Reuters) - HLS Therapeutics Inc HLS.TO :
* HLS THERAPEUTICS ANNOUNCES Q3 FISCAL 2021 FINANCIAL
RESULTS
* HLS THERAPEUTICS INC - Q3 2021 REVENUE OF $15.1 MILLION
* HLS THERAPEUTICS INC - Q3 2021 REVENUE WAS $15.1 MILLION
COMPARED TO $13.1 MILLION IN Q3 2020
* HLS THERAPEUTICS INC - QTRLY LOSS PER SHARE $0.06
Source text for Eikon: ID:nCNWcQXSma
Further company coverage: HLS.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on HLS Therapeutics
See all newsCanada Research Roundup: CIBC ,HLS Therapeutics, TD Bank Group
Canada's HLS Therapeutics Q1 revenue rises on Vascepa growth, reaffirms 2026 guidance
Canada's HLS Therapeutics Q4 revenue slightly beats on Vascepa strength
Brief: Esperion Partner announces HLS Therapeutics received approval Of NILEMDO for the reduction of LDL-cholesterol in canadians at risk of cardiovascular disease
Brief: HLS Therapeutics announces Health Canada approval of NILEMDO for the reduction of LDL-Cholesterol in Canadians at risk of cardiovascular disease